DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Algazi AP, Cha E, Ortiz-Urda SM et al
The combination of axitinib followed by paclitaxel/carboplatin yields extended survival in advanced BRAF wild-type melanoma: results of a clinical/correlative prospective phase II clinical trial.
Br J Cancer 2015;
112: 1326-1331
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.